The Crosstalk of RAS with the TGF-&bgr; Family During Carcinoma Progression and its Implications for Targeted Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|10|8|849-857

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.8, 2010-12, pp. : 849-857

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Natural Products and Transforming Growth Factor-beta (TGF-&bgr;) Signaling in Cancer Development and Progression

By  

Current Cancer Drug Targets, Vol. 13, Iss. 5, 2013-06 ,pp. : 500-505

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Ideas of Gene Therapy for Atherosclerosis: Modulation of Cellular Signal Transduction of TGF-&bgr; Family

By  

Current Pharmaceutical Design, Vol. 12, Iss. 7, 2006-03 ,pp. : 877-886

Bentham Science Publishers

Access to resources Recommend Favorite

TGF-&bgr;: Its Role in Asthma and Therapeutic Potential

By  

Current Drug Targets, Vol. 7, Iss. 5, 2006-05 ,pp. : 547-565

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokines and Invertebrates: TGF-&bgr; and PDGF

By  

Current Pharmaceutical Design, Vol. 12, Iss. 24, 2006-08 ,pp. : 3025-3031

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of the TGF-&bgr; Superfamily and their Clinical Applications

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-11 ,pp. : 1255-1261

Bentham Science Publishers

Access to resources Recommend Favorite